Patient misidentification continues to pose a persistent safety risk throughout the NHS, yet it remains inadequately acknowledged and researched, a healthcare safety watchdog has warned. A new report ...
Author: Dr. Sean Kelly, MD, Chief Medical Officer and VP Customer Strategy, Healthcare at Imprivata and Attending physician, Beth Israel Lahey Health, Assistant Professor of Emergency Medicine, ...
The direct impact of antimicrobial stewardship programs (ASP) and infectious disease (ID) consultations on patients' clinical diagnoses remains unknown. We assessed their influence on improving the ...
Imprivata, a health IT security company, has unveiled a new adoption program for its product Imprivata PatientSecure. Imprivata PatientSecure aims to eliminate patient misidentification at all points ...
Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma Getting the right treatment to the right patient remains the holy grail of oncology. Adding ...
Hospitals can’t provide high-quality care if patient misidentification occurs, as the errors resulting from misidentification can have significant consequences for patient safety and the organizations ...